Overactive bladder in patients with infravesical obstruction caused by prostatic adenoma


Cite item

Full Text

Abstract

According to the literature, overactive bladder (OB) occurs in 52-80% men with infravesical obstruction (IVO) due to prostatic adenoma, 38% patients retain the disorder after surgical correction of the obstruction. Urodynamic investigation of the lower urinary tract (LUT) function was conducted in 206 patients with prostatic adenoma admitted to the urological clinic of I.M. Sechenov Moscow Medical Academy. All of them had LUT obstruction. Detrusor overactivity was detected in 58,25% cases. This bladder dysfunction played a leading role in development of IVO complications (vesicoureteral reflux, ureterohydronephrosis) entailing marked disorder of the upper urinary tract disorder - chronic renal failure. Thus, early detection of the cause of urodynamic disorders in IVO patients has a great practical value for functional results of surgery.

References

  1. Milsom I., Abrams P., Cardozo L. et al. How widespread are the symptoms of an overactive bladder and how are they managed? A populationbased prevalence study. Br. J. Urol. Int. 2001; 87: 760.
  2. Holm N. R., Horn Т., Hald T. Detrusor in ageing and obstruction. Scand. J. Urol. Nephrol. 1995; 29: 45.
  3. Мазо Е. Б., Школьников М. Е., Кривобородов Г. Г. Гиперактивный мочевой пузырь у больных пожилого возраста. Consilium Medicum. 2006; 8 (12): 97-102.
  4. Wein A. J. Diagnosis and treatment of the overactive bladder. Urology. 2003; 62: 20-27.
  5. Knutson Т., Edlung C., Fall M., Dahlstrand С. ВРН with coexisting overactive bladder dysfunction - an everyday urological dilemma. Neurourol. and Urodyn. 2001; 20: 237-247.
  6. Hashim H., Abrams P. Bladder outlet obstruction, bladder contractility and detrusor overactivity: is there a link. In: 6th International consultation on new developments in prostate cancer and prostate diseases. June 24-27, 2005, Paris, France. Paris; 2005. Abst. 29.
  7. Steers W. D., De Groat W. C. Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J. Urol. Baltimore. 1988; 140: 864-871.
  8. Sibley G. N. The physiological response of the detrusor muscle to experimental bladder outflow obstruction in the pig. Br. J. Urol. 1987; 60: 332-336.
  9. Perlberg S., Caine M. Adrenergic response of bladder muscle in prostatic obstruction: its relation to detrusor instability. Urology 1982; 20: 524-527.
  10. Rohner Т., Lepor H. Pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. Rev. Urol. 2004; 6 (Suppl. 9): 310.
  11. Abdel-Khalek M., Nabieh A., Ibrahiem E. Urol. Suppl. 2006; 5 (2): 120.
  12. Мазо Е. Б., Кривобородов Г. Г. Гиперактивный мочевой пузырь. М.: Вече; 2003.
  13. Лоран О. Б., Вишневский Е. Л., Вишневский А. Е. Лечение расстройств мочеиспускания у больных доброкачественной гиперплазией простаты α-адреноблокаторами. М.; 1998. 20-21.
  14. Пытель Ю. А., Винаров А. З. Этиология и патогенез гиперплазии предстательной железы. В кн.: Доброкачественная гиперплазия предстательной железы. М.; 1999. 21-37.
  15. Гаджиева З. К. Уродинамические исследования в диагностике и лечении нарушений мочеиспускания: Дис. ... д-ра мед. наук. М.; 2009.
  16. Ohtake A., Ukai M., Hatanka Т. et al. In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats. Eur. J. Pharmacol. 2004; 492: 243-250.
  17. Abrams P. et al. Neurourol. and Urodyn. 2001; 29: 847-848. 18.
  18. Athanasopoulos et ai. Combination treatment with an alpha-Blocker plus an anticholinergic improves quality of fife in patients with bladder outlet obstruction. A prospective, randomized, controlled study. J. Neurourol. Urodyn. 2002; 21: 308-309.
  19. Кривобородов Г. Г., Школьников М. Е., Мазо Е. Б. Детрузитол в лечении симптомов ГМП у мужчин. В кн.: Всероссийская конф. "Мужское здоровье", Москва, 19-21 нояб. 2003. М.; 2003. 154.
  20. Kaplan S. A., McCammon K., Fincher R. et al. Safety and tolerability of soiifenacin add-on therapy to a-blocker treated men with residual urgency and frequency. J. Urol. (Baltimore) 2009; 182: 2825-2830.
  21. Chapple С. Antimuscarinics in men with lower urinary tract symptoms suggestive bladder outlet obstruction due to bening prostatic hyperplasia. Curr. Opin. Urol. 2010; 20: 43-48.
  22. O'Leary M. P. Lower urinary tract symptoms/benign prostatic hyperpiasia: maintaining symptom control and reducing complications. Urology 2003. Sep; 62 (3, Suppl. 1): 15-23.
  23. Djavan B. et al. Lower urinary tract symptoms/benign prostatic hyperplasia; fast control of the patients quality of life. Urology 2003; 62 (3, Suppl. 1): 6-14.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies